The WeACT Program for Family Caregivers of People Living With Dementia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of South Florida
About this trial
The goal of this clinical trial is to learn whether WeACT, a self-paced, web-based program, is feasible and helpful for adult family caregivers of a relative living with dementia. WeACT is based on acceptance and commitment therapy (ACT), which teaches skills to handle difficult thoughts and feelings and take steps toward what matters most.
The main questions this study aims to answer are:
* Can caregivers complete WeACT as planned? * Do caregivers show improvements in mental health and coping after using WeACT? * What are caregivers' experiences with the program, and what suggestions do they have to improve it?
Participants will:
* Complete six self-paced weekly online modules and use the daily practice section during the program. * Complete online questionnaires before starting and after completing the program. * Take part in one online interview about their experience.
Eligibility criteria
Qualifiers
Are community-dwelling adults aged 18 years or older who have primary caregiving responsibilities for a relative diagnosed with dementia;
Present mild to moderately severe depressive symptoms, as measured by the Patient Health Questionnaire-9 (PHQ-9), with scores between 5 and 19; and
Have access to a web-enabled device, such as a smartphone, tablet, laptop, or desktop computer, with internet access.
Disqualifiers
Have cognitive, physical, or sensory impairments, or are unable to complete study procedures in English, that may impede study participation;
Present severe depressive symptoms, defined as PHQ-9 scores of 20 or higher;
Report having thoughts of harming themselves or attempting suicide within the past six months;
Have previously participated in a research study involving an ACT program;
Trial design
Treatments tested in this trial
- WeACT
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
University of South Florida
Lead sponsor
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov